406 related articles for article (PubMed ID: 21128703)
1. Mitochondria and redox signaling in steatohepatitis.
Morris EM; Rector RS; Thyfault JP; Ibdah JA
Antioxid Redox Signal; 2011 Jul; 15(2):485-504. PubMed ID: 21128703
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial dysfunction in nonalcoholic steatohepatitis.
Serviddio G; Bellanti F; Vendemiale G; Altomare E
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):233-44. PubMed ID: 21476918
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.
Begriche K; Massart J; Robin MA; Borgne-Sanchez A; Fromenty B
J Hepatol; 2011 Apr; 54(4):773-94. PubMed ID: 21145849
[TBL] [Abstract][Full Text] [Related]
4. A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis.
Serviddio G; Bellanti F; Giudetti AM; Gnoni GV; Petrella A; Tamborra R; Romano AD; Rollo T; Vendemiale G; Altomare E
J Pharmacol Exp Ther; 2010 Mar; 332(3):922-32. PubMed ID: 20008062
[TBL] [Abstract][Full Text] [Related]
5. Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury.
Serviddio G; Bellanti F; Tamborra R; Rollo T; Capitanio N; Romano AD; Sastre J; Vendemiale G; Altomare E
Gut; 2008 Jul; 57(7):957-65. PubMed ID: 18308829
[TBL] [Abstract][Full Text] [Related]
6. Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease.
Grattagliano I; Montezinho LP; Oliveira PJ; Frühbeck G; Gómez-Ambrosi J; Montecucco F; Carbone F; Wieckowski MR; Wang DQ; Portincasa P
Biochem Pharmacol; 2019 Feb; 160():34-45. PubMed ID: 30508523
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial involvement in non-alcoholic steatohepatitis.
Serviddio G; Sastre J; Bellanti F; Viña J; Vendemiale G; Altomare E
Mol Aspects Med; 2008; 29(1-2):22-35. PubMed ID: 18061659
[TBL] [Abstract][Full Text] [Related]
8. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
[No Abstract] [Full Text] [Related]
9. High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes.
Loza-Medrano SS; Baiza-Gutman LA; Manuel-Apolinar L; García-Macedo R; Damasio-Santana L; Martínez-Mar OA; Sánchez-Becerra MC; Cruz-López M; Ibáñez-Hernández MA; Díaz-Flores M
Mol Biol Rep; 2020 Jan; 47(1):337-351. PubMed ID: 31650383
[TBL] [Abstract][Full Text] [Related]
10. Peroxisomal beta-oxidation and steatohepatitis.
Rao MS; Reddy JK
Semin Liver Dis; 2001; 21(1):43-55. PubMed ID: 11296696
[TBL] [Abstract][Full Text] [Related]
11. Fibrosis in alcoholic and nonalcoholic steatohepatitis.
Bataller R; Rombouts K; Altamirano J; Marra F
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):231-44. PubMed ID: 21497741
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet.
Romestaing C; Piquet MA; Letexier D; Rey B; Mourier A; Servais S; Belouze M; Rouleau V; Dautresme M; Ollivier I; Favier R; Rigoulet M; Duchamp C; Sibille B
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E110-9. PubMed ID: 17986629
[TBL] [Abstract][Full Text] [Related]
13. Hepatic mitochondrial dysfunction induced by fatty acids and ethanol.
Gyamfi D; Everitt HE; Tewfik I; Clemens DL; Patel VB
Free Radic Biol Med; 2012 Dec; 53(11):2131-45. PubMed ID: 23010494
[TBL] [Abstract][Full Text] [Related]
14. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
Gambino R; Musso G; Cassader M
Antioxid Redox Signal; 2011 Sep; 15(5):1325-65. PubMed ID: 20969475
[TBL] [Abstract][Full Text] [Related]
15. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease.
Koliaki C; Roden M
Mol Cell Endocrinol; 2013 Oct; 379(1-2):35-42. PubMed ID: 23770462
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of redox dysregulation in alcoholic and nonalcoholic fatty liver disease.
Feldstein AE; Bailey SM
Antioxid Redox Signal; 2011 Jul; 15(2):421-4. PubMed ID: 21254858
[TBL] [Abstract][Full Text] [Related]
17. Modulation of hepatic redox status and mitochondrial metabolism by exercise: therapeutic strategy for liver diseases.
Ascensão A; Martins MJ; Santos-Alves E; Gonçalves IO; Portincasa P; Oliveira PJ; Magalhães J
Mitochondrion; 2013 Nov; 13(6):862-70. PubMed ID: 23880173
[TBL] [Abstract][Full Text] [Related]
18. Importance of iron and iron metabolism in nonalcoholic fatty liver disease.
Baptista-Gonzalez H; Chavez-Tapia NC; Zamora-Valdés D; Uribe M; Mendez-Sanchez N
Mini Rev Med Chem; 2008 Feb; 8(2):171-4. PubMed ID: 18289100
[TBL] [Abstract][Full Text] [Related]
19. Liver mitochondrial function and redox status in an experimental model of non-alcoholic fatty liver disease induced by monosodium L-glutamate in rats.
Lazarin Mde O; Ishii-Iwamoto EL; Yamamoto NS; Constantin RP; Garcia RF; da Costa CE; Vitoriano Ade S; de Oliveira MC; Salgueiro-Pagadigorria CL
Exp Mol Pathol; 2011 Dec; 91(3):687-94. PubMed ID: 21821020
[TBL] [Abstract][Full Text] [Related]
20. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
Serviddio G; Bellanti F; Vendemiale G
Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
